首页> 外文期刊>Nature >The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
【24h】

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

机译:癌细胞系百科全书实现了抗癌药物敏感性的预测模型

获取原文
获取原文并翻译 | 示例
           

摘要

The systematic translation of cancer genomic data into knowledge of tumour biology and therapeutic possibilities remains challenging. Such efforts should be greatly aided by robust predinical model systems that reflect the genomic diversity of human cancers and for which detailed genetic and pharmacological annotation is available1. Here we describe the Cancer Cell Line Encyclopedia (CCLE): a compilation of gene expression, chromosomal copy number and massively parallel sequencing data from 947 human cancer cell lines. When coupled with pharmacological profiles for 24 anticancer drugs across 479 of the cell lines, this collection allowed identification of genetic, lineage, and gene-expression-based predictors of drug sensitivity. In addition to known predictors, we found that plasma cell lineage correlated with sensitivity to IGF1 receptor inhibitors; AHR expression was associated with MEK inhibitor efficacy in NRAS-mutant lines; and SLFN11 expression predicted sensitivity to topoisomerase inhibitors. Together, our results indicate that large, annotated cell-line collections may help to enable predinical stratification schemata for anticancer agents. The generation of genetic predictions of drug response in the precnnical setting and their incorporation into cancer clinical trial design could speed the emergence of 'personalized' therapeutic regimens.
机译:将癌症基因组数据系统转换为肿瘤生物学知识和治疗可能性仍然具有挑战性。可以通过反映人类癌症的基因组多样性并且可以使用详细的遗传和药理注释的强大的常规模型系统极大地协助此类工作。在这里,我们描述了癌细胞系百科全书(CCLE):来自947个人类癌细胞系的基因表达,染色体拷贝数和大规模并行测序数据的汇编。当与横跨479种细胞系的24种抗癌药的药理学特征相结合时,该收集物可以鉴定基于遗传,谱系和基因表达的药物敏感性预测因子。除了已知的预测因子外,我们发现浆细胞谱系与对IGF1受体抑制剂的敏感性相关。在NRAS突变株中,AHR的表达与MEK抑制剂的功效有关。和SLFN11表达预测对拓扑异构酶抑制剂的敏感性。在一起,我们的结果表明,大型的注释细胞系集合可能有助于使抗癌药具有常规的分层方案。在先行环境中药物反应的遗传预测的产生以及将其纳入癌症临床试验设计中可以加快“个性化”治疗方案的出现。

著录项

  • 来源
    《Nature》 |2012年第7391期|p.603-607|共5页
  • 作者单位

    The Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA,Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115.USA,Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA;

    Novartis Institutes for Biomedical Research, Cambridge,Massachusetts 02139, USA;

    The Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA;

    Novartis Institutes for Biomedical Research, Cambridge,Massachusetts 02139, USA;

    et al;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号